Preferred Label : Bevacizumab/Carboplatin/Gemcitabine Regimen;
NCIt synonyms : GC Plus Bev; Bevacizumab/Carboplatin/Gemcitabine; Gemcitabine/Carboplatin/Bevacizumab; Gemcitabine/Carboplatin/Bevacizumab Regimen; Avastin/Paraplatin/Gemzar; GC Bev;
NCIt related terms : Carboplatin and Gemcitabine (GCb) and Bevacizumab; Carboplatin and Gemcitabine (GCb) and Bevacizumab-maly; Carboplatin and Gemcitabine (GCb) and Bevacizumab-onbe; Carboplatin and Gemcitabine (GCb) and Bevacizumab-aybi; Carboplatin and Gemcitabine (GCb) and Bevacizumab-equi; Carboplatin and Gemcitabine (GCb) and Bevacizumab-awwb; Carboplatin and Gemcitabine (GCb) and Bevacizumab-bvzr; Carboplatin and Gemcitabine (GCb) and Bevacizumab-adcd; Carboplatin, Gemcitabine, Bevacizumab; Carboplatin, Gemcitabine, Bevacizumab-onbe; Carboplatin, Gemcitabine, Bevacizumab-maly; Carboplatin, Gemcitabine, Bevacizumab-adcd; Carboplatin and Gemcitabine (GCb) and Bevacizumab-tnjn; Carboplatin, Gemcitabine, Bevacizumab-bvzr; Carboplatin, Gemcitabine, Bevacizumab-aybi; Carboplatin, Gemcitabine, Bevacizumab-awwb; Carboplatin, Gemcitabine, Bevacizumab-equi;
NCIt definition : A regimen consisting of gemcitabine, carboplatin, and bevacizumab that may be used
in the treatment of ovarian, fallopian tube, or primary peritoneal cancer.;
NCI Metathesaurus CUI : CL969482;
Codes from synonyms : 31967; 127202; 127424; 127646; 127498; 127350; 127572; 127276; 142162; 139859; 119990; 139861; 139860; 139865; 139864; 139863; 139862;
Origin ID : C160552;
UMLS CUI : C5205353;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
